A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory di...
A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Endocan is expressed by the lung endothelial cells and upregulated by pro-inflammatory conditions. Because elevated pro-inflammatory cytokines are hallmarks of severe SARS-CoV-2 infection [1], and that the lung is the organ preferentially affected, we measured endocan in patients with COVID-19 pneumonia. According to the Berlin definition of acute...
Alternative Titles
Full title
A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_7eaacf53ed8d4309ab5e976fba0025fe
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7eaacf53ed8d4309ab5e976fba0025fe
Other Identifiers
ISSN
1364-8535
E-ISSN
1364-8535,1466-609X,1366-609X
DOI
10.1186/s13054-021-03589-3
